Jazz Pharmaceuticals plc Operating Lease, Liability, Noncurrent
Jazz Pharmaceuticals plc (JAZZ) had Operating Lease, Liability, Noncurrent of $43.60 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-03
- 2026-06-30: Operating Lease, Liability, Noncurrent $43.60M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $47.30M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $50.90M; Operating Lease, Liability, Noncurrent as first filed $50.89M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $53.43M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $43.60M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $47.30M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $50.90M 10-Q · filed 2026-08-03 | $50.89M 10-K · filed 2026-02-24 |
| 2025-09-30 | $53.43M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $55.11M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $38.78M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $38.94M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $71.11M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $67.62M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $56.16M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $59.23M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $61.89M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $65.55M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $72.09M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $71.84M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $72.98M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $77.84M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $83.08M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $87.20M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $89.36M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $156.56M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $136.02M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $140.03M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $141.93M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $144.26M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $147.11M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $151.23M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $153.43M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $156.29M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $154.07M 10-Q · filed 2019-05-07 | |
| 2019-01-01 | $153.16M 10-K · filed 2020-02-25 | |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |